Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $1.9993 per ML under NDC 00832142510. Its NADAC has been published 182 times since May 24, 2023.

FDA first approved this application on Dec 12, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

Brimonidine Tartrate and Timolol Maleate
$1.9993per ML

Strength

2; 5 mg/mL; mg/mL

NDC

00832142510

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215598

FDA Approved

12/12/2022

TE Code

AB

On Market Since

12/15/2022

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 182 times since May 24, 2023, and over the history we have for it it has declined 89.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.9993 per ML
All-time high$19.2842 (Jun 14, 2023)
All-time low$1.9993 (Oct 21, 2026)
52-week high$2.8127
52-week low$1.9993
Median price$8.0599
Average price$8.5029
Largest weekly change+56.9% (May 22, 2024)
Weeks tracked182
Tracking sinceMay 24, 2023

Price History

1W

0.0%

1M

-7.1%

3M

-25.3%

6M

-21.1%

1Y

-35.8%

3Y

-85.5%

5Y

N/A

All

-89.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Upsher-Smith Laboratories LLC, is $1.9993 per ML (NDC 00832142510), effective Nov 11, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 89.6%. It has been tracked across 182 weekly CMS publications since May 24, 2023.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since May 24, 2023, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $1.9993 (Oct 21, 2026) to a high of $19.2842 (Jun 14, 2023), with a median of $8.0599 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BRIMONIDINE-TIMOLOL 0.2%-0.5% in a comparable dosage form, but none are currently priced below it.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 00832142510) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.